Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Future of Self-Care Regulation in Europe: Maximising Innovation

This article was originally published in SRA

Executive Summary

Hubertus Cranz of industry association AESGP describes how regulations for non-prescription medicines must change.

You may also be interested in...



The EMA at 20: An increasing impact on the non-prescription medicines market

The EU regulatory system has brought some positive results in the area of non-prescription medicines, but further progress is needed to meet the expectations of the self-care sector, says Hubertus Cranz.

The EMA at 20: An increasing impact on the non-prescription medicines market

The EU regulatory system has brought some positive results in the area of non-prescription medicines, but further progress is needed to meet the expectations of the self-care sector, says Hubertus Cranz.

UsernamePublicRestriction

Register

PS115521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel